Napredna pretraga

Pregled bibliografske jedinice broj: 453890

Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?


Čimić, Mislav; Smoljanović, Tomislav; Bojanić, Ivan
Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? // Spine, 35 (2010), 3; 361-362 doi:10.1097/BRS.0b013e3181cb4651 (međunarodna recenzija, pismo, znanstveni)


Naslov
Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
(Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? Spine 2009 ; 34:885-9.)

Autori
Čimić, Mislav ; Smoljanović, Tomislav ; Bojanić, Ivan

Izvornik
Spine (0362-2436) 35 (2010), 3; 361-362

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo, znanstveni

Ključne riječi
Recombinant human bone morphogenetic protein type 2 ; posterior cervical fusion ; long-term complications ; instrument failure

Sažetak
The authors miscalculated incidence of the long-term complications misleading the readers related to the safety issue of rhBMP-2 use for posterior cervical fusions.

Izvorni jezik
Engleski



POVEZANOST RADA


Projekt / tema
108-0000000-3652 - Genska terapija mineraliziranih tkiva (Marko Pećina, )

Ustanove
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati